The Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO) were founded by Professor Axel Haverich at the Hannover Medical School (MHH) in 1996, based on funding from the prestigious Leibniz prize awarded by the DFG.
LEBAO is one of the central pillars of the Cluster of Excellence "REBIRTH" and is closely linked to the Department of Cardiothoracic, Transplantation and Vascular Surgery at the MHH. The resulting synergies between application-driven basic research and clinical practice are underpinned by the co-directorship of a clinical director, Professor Axel Haverich, and a research director, Professor Ulrich Martin.
Within LEBAO, our research focuses on different aspects of regenerative medicine and organ transplantation. The close alignment between basic research and the clinic allows focused approaches in research and development, and promotes an accelerated translation of innovative therapeutic concepts into clinical practice. Under the direction of Professor Ulrich Martin, research projects are currently underway in the following priority areas:
Bioartificial lung (Head: Axel Haverich, MD)
Molecular biotechnology and stem cell research (Head: Ulrich Martin, PhD)
Tissue engineering (Head: Andres Hilfiker, PhD)
Projects in all areas of research aim at the development of new therapies for the treatment of cardiovascular and respiratory diseases. We collaborate closely with other projects within the MHH and the Cluster of Excellence "REBIRTH" , as well as with the Competence Center for Cardiovascular Implants (Medimplant), the University of Hannover, corlife oHG, CrossBIT joint research centre for medical technology and numerous other national and international scientific institutions and industry partners.
Axel Haverich, MD, Hannover
Ulrich Martin, PhD, Hannover
Wolfgang Mueller-Ruchholtz, MD, Kiel